Researchers at Emory University have provided compelling evidence supporting the existence of an inflammatory subtype of major depression, a breakthrough that could transform how this complex disorder ...

Recent research shows ketamine and a low-dose opioid significantly decreases suicidal thinking and risks. As suicide is the ...

Spravato (esketamine) is a nasal spray used for depression and was approved by the FDA in 2019. It is specifically for treatment-resistant depression, meaning depression symptoms that have not gotten ...

A team of leading clinical research scientists from the Departments of Psychiatry and Dermatology at the Icahn School of Medicine at Mount Sinai has found that the serum of patients with major ...

Auvelity is a medicine for major depressive disorder, commonly known as depression. It was approved by the FDA in 2022. It is an oral tablet that contains a combination of two medicines called ...

One of the first real-world studies of psilocybin therapy suggests meaningful improvements in treatment-resistant depression outside the controlled setting of clinical trials.

Discover the nine subtypes of depression and their key symptoms. Since treatment can vary for each type, it’s important to consult your doctor for guidance. Most people go through periods of deep ...

Editor’s Note: If you or someone you know is struggling with suicidal thoughts or mental health matters, please call the 988 Suicide and Crisis Lifeline, or visit the hotline’s website. Sen. John ...